IP Library Granted Patent US 9,024,025
Granted Patent B2
US 9,024,025 · App. 14/225,018 · Granted May 5, 2015

Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin

Inventors: David J. Moody (Fife, GB); Jonathan W. Wiffen (Craigavon, GB)
Assignee: Redx Pharma Limited
C07D405/06C07D309/10C07D309/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,024,025
App. No.
14/225,018
Granted
May 5, 2015
Kind
B2
Abstract

Provided are a compound of formula (5) and a process for its preparation wherein: R 1 represents an alkyl group; R 2 represents an aryl group; R 3 represents a protecting group or an alkyl group; R 4 represents a protecting group or a SO 2 R 5 group where R 5 is an alkyl group; R 6 represents (PR 7 R 8 ) + X − or P(═O)R 7 R 8 in which X is an anion and R 7 and R 8 each independently is an alkyl, aryl, alkoxy, or aryloxy group; P 1 represents hydrogen or a protecting group; and W represents ═O or OP 2 , in which P 2 represents hydrogen or a protecting group.

Claims (38)

1. A process for the preparation of a compound of formula (5)

comprising coupling a compound of formula (3)

with a compound of formula (4)

wherein:

R 1 represents an alkyl group;

R 2 represents an aryl group;

R 3 represents a protecting group or an alkyl group;

R 4 represents a protecting group or a SO 2 R 5 group where R 5 is an alkyl group;

R 6 represents (PR 7 R 8 ) + X − or P(═O)R 7 R 8 in which X is an anion and R 7 and R 8 each independently is an alkyl, aryl, alkoxy, or aryloxy group;

P 1 represents hydrogen or a protecting group; and

W represents —OP 2 , in which P 2 represents hydrogen or a protecting group.

2. A compound of formula (5)

wherein:

R 1 represents an alkyl group;

R 2 represents an aryl group;

R 3 represents hydrogen, a protecting group, or an alkyl group;

R 4 represents a protecting group or a SO 2 R 5 group where R 5 is an alkyl group;

P 1 represents hydrogen or a protecting group; and

W represents —OP 2 , in which P 2 represents hydrogen or a protecting group.

3. The process of claim 1 , wherein each of R 7 and R 8 is a phenyl group.

4. The process of claim 1 , wherein R 1 represents a C 1-6 alkyl group.

5. The process of claim 4 , wherein R 1 represents an isopropyl group.

6. The process of claim 1 , wherein R 2 is 4-fluorophenyl group.

7. The process of claim 1 , wherein R 3 represents a C 1-6 alkyl group.

8. The process of claim 1 , wherein R 3 represents a methyl group.

9. The process of claim 1 , wherein R 5 is a C 1-6 alkyl group.

10. The process of claim 9 , wherein R 5 is a methyl group.

11. The process of claim 1 , wherein P 1 represents hydrogen or a protecting group selected from the group consisting of tetrahydropyranyl, benzyl, methyl, silyl, and benzoyl.

12. The process of claim 1 , wherein P 2 represents a protecting group selected from the group consisting of tetrahydropyranyl, benzyl, methyl, silyl, and benzoyl.

13. The compound of claim 2 , wherein R 1 represents a C 1-6 alkyl group.

14. The compound of claim 13 , wherein R 1 represents an isopropyl group.

15. The compound of claim 2 , wherein R 2 is 4-fluorophenyl group.

16. The compound of claim 2 , wherein R 3 represents a C 1-6 alkyl group.

17. The compound of claim 2 , wherein R 3 represents a methyl group.

18. The compound of claim 2 , wherein R 5 is a C 1-6 alkyl group.

19. The compound of claim 18 , wherein R 5 is a methyl group.

20. The compound of claim 2 , wherein P 1 represents hydrogen or a protecting group selected from the group consisting of tetrahydropyranyl, benzyl, methyl, silyl, and benzoyl.

21. The compound of claim 2 , wherein P 2 represents a protecting group selected from the group consisting of tetrahydropyranyl, benzyl, methyl, silyl, and benzoyl.

Assignments (6)
CHANGE OF NAME Recorded Apr 17, 2015
From: REDX PHARMA LIMITED
To: REDX PHARMA PLC
Reel/Frame 035455/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2014
From: MOODY, DAVID J.; WIFFEN, JONATHAN W.
To: AVECIA PHARMACEUTICALS LIMITED
Reel/Frame 032760/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2014
From: PIRAMAL HEALTHCARE UK LIMITED
To: BRADFORD PHARMA LIMITED
Reel/Frame 032760/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2014
From: BRADFORD PHARMA LIMITED
To: REDX PHARMA LIMITED
Reel/Frame 032760/0370 →
CHANGE OF NAME Recorded Apr 25, 2014
From: AVECIA PHARMACEUTICALS LIMITED
To: NPIL PHARMACEUTICALS (UK) LIMITED
Reel/Frame 032764/0419 →
CHANGE OF NAME Recorded Apr 25, 2014
From: NPIL PHARMACEUTICALS (UK) LIMITED
To: PIRAMAL HEALTHCARE UK LIMITED
Reel/Frame 032764/0438 →
Priority Claims (1)
GB 0406757.5 · Mar 26, 2004 · national
Continuity (2)
Division 10594380
Related Publication 20140316135A1 · Oct 23, 2014